Everand Logo

Welcome to Everand!

  • STAT

    Drug pricing advocates to spend $1M on ads supporting Trump proposal

    A drug pricing advocacy group is launching a $1 million ad campaign to promote a Trump administration proposal to align American drug prices with those in other wealthy nations.
    by Lev Facher Jan 10, 2019 2 minutes

    WASHINGTON — A drug pricing advocacy group on Thursday announced a roughly $1 million ad campaign to boost a Trump administration proposal to align American drug prices with those in other wealthy nations, providing an outside boost to a policy concept that the drug industry has vocally opposed.

    The same advocacy group, Patients for Affordable Drugs, via its political arm to endorse

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Wegovy Insurance Coverage, Zepbound Shortages, And More
    The first major U.S. health insurers have agreed to start paying for the Wegovy weight loss drug for certain people on Medicare with heart conditions.
    STAT1 min read
    Opinion: HHS’s Proposed Rule Pays Lip Service To Addressing The Climate Crisis, The Greatest Threat To Human Health
    HHS's proposal for addressing the climate crisis serves as an example of what historian and philosopher Hannah Arendt defined as the "banality of evil."
    STAT1 min read
    STAT+: Pharmalittle: We’re Watching A Ban Of Compounded Versions Of GLP-1s, A Biogen Acquisition, And More
    Good morning from San Diego. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalittle campus. I’m not a coffee drinker, but who needs caffeine when you’ve got the raw adr

    Related Books & Audiobooks